“After consideration of the public comments received, we are finalizing our proposal to revise the definition of a dose for CPT code 95165 (Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses) from a 1 cc aliquot to a single injection from a multidose vial, consistent with the definition used for CPT codes 95115 and 95117.”
Source: Federal Register, Vol. 91, No. 215, pg. 71168
Based on the above excerpt from the 2027 CMS Fee schedule, a billable unit for CMS (Medicare and Medicaid) is now the equivalent of a clinical dose. As an example, a 5 cc vial with 10 clinical doses would have 10 in the units box for billing.
This change in the CMS definition of a dose will have a huge impact on AAOA members, who will now be reimbursed for actual immunotherapy doses mixed, rather than cc of treatment vial. This is a direct result of a unified effort of the AAOA and our general allergy colleagues at ACAAI.
As background excerpted from the CMS release, in 2020, CMS issued a new directive on what constituted a billable unit. Rather than the more typical clinical dose, CMS identified a billable unit as 1 cc regardless of the dose aliquot. So a typical 5 cc vial with 10 clinical doses was billed as 5 billable units.
Now, after the AAOA, ACAAI, and others committed to allergy patient care unified effort in supplying CMS with data to support the shortcoming of the current definition of a dose, CMS agrees that the current volume-based definition no longer reflects contemporary clinical practice. CMS also agrees this discrepancy has had the practical effect of valuing only a fraction of the doses actually prepared and administered. Finally, CMS recognizes that certain allergen combinations cannot be safely consolidated into a single vial due to proteolytic activity and cross-reactivity.
CMS is still evaluating whether it will reconsider the 30-unit per-claim medically unlikely edit (MUE) applied to CPT code 95165.
Based on the above, beginning January 1, 2027, the billable unit for dose under Medicare/Medicaid is up to 30 units per claim based on clinical doses. A 1-cc aliquots is no longer considered as the billable unit.
Because the policy was made on the national level, you may need to help educate your local Medicare Administrative Contractor (MACs) on the new ruling. We would encourage using the full text from the CMS Fee Schedule proactively to help educate your local MAC. Perhaps include a copy with your bills for Q1 as back up.
In regard to private payers, we recognize many (UHC, BCBS, Aetna, for example) have adopted the 1-cc billable unit as their reimbursement policy. Now that CMS is aligned with the CPT definition, we are hoping we can help reverse these payer policies. If one of your payers has implemented a 1-cc billable unit, please share the payer policy and any key contact information. Together we can work to improve reimbursement.
For the full text from the CMS release, Allergy Immunotherapy (CPT Code 95165) (page 493)




